title: Gut bacteria and health foods--the European perspective.
abstract: Probiotics, prebiotics, and synbiotics aimed at improving intestinal health currently represent the largest segment of the functional foods market in Europe, Japan and Australia. Evidence continues to emerge demonstrating that these ingredients have the potential to improve human health in specific intestinal disorders. The European Commission, through its 5th Framework Programme, is presently focusing on a substantial effort in the science of the intestinal microbiota, its interaction with its host and methods to manipulate its composition and activity for the improvement of human health and well being. Eight multicentre and multidisciplinary research projects now cover a range of topics required for the development of efficacious probiotic foods, from understanding probiotic mechanisms at a molecular level; developing technologies to ensure delivery of stable products; and demonstrating safety and efficacy of specific probiotics in defined treatment targets. This concerted research effort promises to provide us with an enhanced understanding of the human intestinal microbiota's role in health and disease, and new approaches and products to tackle a variety of intestinal problems.
authors.affiliation: VTT Biotechnology, Finland. maria.saarela@vtt.fi
authors.forename: M
authors.initials: M
authors.lastname: Saarela
authors.forename: L
authors.initials: L
authors.lastname: Lähteenmäki
authors.forename: R
authors.initials: R
authors.lastname: Crittenden
authors.forename: S
authors.initials: S
authors.lastname: Salminen
authors.forename: T
authors.initials: T
authors.lastname: Mattila-Sandholm
mesh_terms: D004064:Digestive System / Q000382:microbiology*; D005060:Europe; D058870:Food, Organic; D005767:Gastrointestinal Diseases / Q000382:microbiology* / Q000517:prevention & control; D006293:Health Promotion; D006801:Humans; D019936:Probiotics / Q000008:administration & dosage / Q000627:therapeutic use; D012449:Safety; D016896:Treatment Outcome